VICTORY CAPITAL MANAGEMENT INC - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 175 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2024$583,600
+24.3%
65,573
+41.5%
0.00%
Q1 2024$469,596
-37.4%
46,357
-37.8%
0.00%
-100.0%
Q4 2023$749,882
-35.0%
74,541
-39.4%
0.00%0.0%
Q3 2023$1,152,791
-54.9%
123,030
+18.1%
0.00%
-66.7%
Q2 2023$2,554,750
+12.7%
104,148
+7.0%
0.00%0.0%
Q1 2023$2,266,009
+18.4%
97,379
+28.7%
0.00%
+50.0%
Q4 2022$1,914,524
+490.9%
75,643
+350.5%
0.00%
Q3 2022$324,000
-34.3%
16,791
-13.3%
0.00%
-100.0%
Q2 2022$493,000
+17.9%
19,372
-5.7%
0.00%
Q1 2022$418,000
-4.6%
20,545
+96.2%
0.00%
Q4 2021$438,000
-1.1%
10,472
+2.8%
0.00%
Q3 2021$443,000
+6.2%
10,188
+15.6%
0.00%
Q2 2021$417,000
-4.6%
8,811
+3.5%
0.00%
Q1 2021$437,000
+90.8%
8,515
-0.2%
0.00%
Q4 2020$229,000
-32.6%
8,536
-13.8%
0.00%
Q3 2020$340,000
-6.8%
9,898
+11.0%
0.00%
Q2 2020$365,000
-24.3%
8,921
-36.6%
0.00%
Q1 2020$482,00014,0600.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$39,700,00030.52%
SB INVESTMENT ADVISERS (UK) LTD 22,216,644$565,858,0004.50%
Zebra Capital Management LLC 25,419$647,0001.90%
Alaska Permanent Fund Corp 2,300,000$58,581,0000.84%
CLARK ESTATES INC/NY 180,000$4,585,0000.79%
Temasek Holdings (Private) Ltd 5,602,553$142,697,0250.78%
SECTOR GAMMA AS 110,223$2,807,0000.63%
Avidity Partners Management LP 758,211$19,312,0000.44%
New Vernon Capital Holdings II LLC 14,501$369,0000.30%
DUALITY ADVISERS, LP 116,415$2,965,0000.29%
View complete list of VIR BIOTECHNOLOGY INC shareholders